Synergy Innovation Co. Ltd

Synergy Innovation Co. Ltd

048870 · KQ · Healthcare / Biotechnology

1,334.00KRW-50.00 (-3.61%)

Price History

Full chart

Market Stats

Previous Close1,384.00
Open1,384.00
Day Range1,330.00 – 1,390.00
52-Week Range1,385.00 – 2,650.00
Volume422.93K
Market Cap140.97B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.10
50-Day Avg1,586.26
200-Day Avg1,950.23

About

Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation " universal transport solutions (SI-UTS); and invests and develops in various fields comprising microorganism, bacteria, and virus. The company also provides pharmaceutical formulations; and develops non-vascular stents. Synergy Innovation Co., Ltd. was founded in 1998 and is headquartered in Seongnam-Si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Gil Hwan Ahn
  • Employees81
  • Headquarters52, Sagimakgol-ro, Seongnam-Si, South Korea, 13210, Korea
  • Websitehttps://www.synergyinno.com

Leadership

  • Mr. Gil Hwan AhnChief Financial Officer, Vice President and Executive Director

Financials

Income Statement

Currency: KRW2006-12-312007-12-312008-12-312009-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue190.20B124.82B94.51B34.90B42.46B61.81B33.35B31.27B14.87B15.62B34.20B42.05B54.59B68.95B30.71B86.54B83.21B90.61B113.05B
Growth (%)--34.38%-24.28%-63.08%+21.68%+45.56%-46.04%-6.24%-52.45%+5.03%+118.96%+22.96%+29.81%+26.31%-55.47%+181.84%-3.84%+8.88%+24.77%
Cost of Revenue130.59B79.42B54.20B23.57B28.38B46.89B25.66B23.64B17.23B9.41B21.39B24.32B35.73B40.09B24.52B47.00B51.61B52.50B62.71B
Gross Profit-------3.32B-2.36B6.20B12.81B17.73B18.85B28.86B6.18B39.54B31.60B38.10B50.34B
Gross Margin-------10.60%-15.90%39.72%37.46%42.17%34.54%41.85%20.13%45.69%37.98%42.05%44.53%
Operating Expense-------8.29B39.61B-2.20B15.65B13.57B19.40B18.70B4.96B16.61B16.62B21.90B31.17B
Operating Income30.27B895.92M------4.98B-41.97B8.41B-2.84B4.16B-544.13M10.16B1.22B22.93B14.98B16.20B19.16B
Operating Margin15.92%0.72%------15.92%-282.25%53.82%-8.31%9.90%-1.00%14.74%3.98%26.49%18.01%17.88%16.95%
EBITDA---------------22.57B33.20B30.57B26.01B
EBITDA Margin---------------26.08%39.90%33.74%23.01%
Net Income26.13B1.97B2.83B-----12.20B-51.32B13.67B-9.28B-1.35B3.35B-21.41B5.72B16.13B2.30B10.37B3.01B
Net Income Margin13.74%1.58%2.99%-----39.02%-345.14%87.53%-27.14%-3.22%6.13%-31.06%18.63%18.64%2.77%11.45%2.66%
R&D----3.06B17.29B14.83B8.70B3.49B912.36M2.23B2.36B3.29B4.02B4.42B----
R&D as % of Total Revenue----7.22%27.97%44.47%27.83%23.45%5.84%6.52%5.61%6.03%5.84%14.40%----
Interest Expense00000000000003.36B2.12B2.76B2.02B4.62B4.44B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%4.87%6.89%3.19%2.43%5.10%3.93%

Balance Sheet

Currency: KRW2006-12-312007-12-312008-12-312009-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets136.78B156.60B179.47B143.00B126.03B130.20B96.56B82.08B16.10B59.67B106.06B122.01B147.29B158.31B202.70B227.38B285.90B314.06B336.89B
Total Liabilities25.29B23.02B44.99B40.73B54.95B54.64B54.31B51.98B35.66B46.21B75.15B68.21B72.24B79.11B88.76B87.46B63.31B131.33B64.49B
Total Equity110.92B133.58B134.48B102.27B70.13B74.27B41.13B30.07B-19.56B13.47B30.91B53.79B75.05B79.21B113.94B139.91B178.05B182.74B211.51B
Cash32.82B17.91B14.44B17.57B6.24B11.22B4.28B185.55M6.01B4.30B7.89B13.31B11.20B18.90B19.00B2.64B61.87B71.48B65.68B
Total Debt---------22.18B47.82B6.11B16.30B10.06B-----
Net Debt------------21.53B3.34B9.67B31.64B---

Cash Flow

Currency: KRW2006-12-312007-12-312008-12-312009-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-23.56B5.40B--2.12B3.39B-1.63B-6.08B-1.17B-4.87B2.81B5.33B10.20B20.42B6.93B35.37B26.47B14.78B
Investing Cash Flow---9.89B----7.90B24.68B-41.31B-50.10B-9.13B-15.14B-4.52B-38.63B-33.53B-28.26B-13.55B-
Financing Cash Flow-21.05B31.13B1.24B7.41B7.00B-5.45B-12.78B36.94B57.17B11.69B7.83B2.08B18.31B10.42B46.35B-3.98B-
Capital Expenditure04.91B7.49B6.42B457.39M1.46B631.48M216.75M63.14M2.82B5.73B6.36B6.97B5.44B2.04B1.00B1.57B1.82B6.98B
Free Cash Flow-------------5.79B18.15B11.75B33.40B24.27B7.80B
Dividends Paid-6.52B422.46M402.86M------521.05M521.05M521.05M521.05M666.04M883.32M1.44B1.23B1.55B
FCF to OCF-------------56.72%88.87%169.45%94.45%91.66%52.79%
Dividend Paid to FCF-------------9.00%3.67%7.52%4.31%5.07%19.82%

Earnings

Report DateJan 27, 2005Jul 22, 2005Oct 25, 2005Feb 7, 2006Apr 26, 2006Jul 24, 2006Oct 29, 2006Feb 8, 2007Apr 30, 2007Jul 30, 2007Oct 29, 2007Feb 5, 2008May 14, 2008Aug 14, 2008Mar 31, 2009Aug 14, 2009Apr 27, 2011Aug 31, 2011Oct 25, 2011Apr 25, 2012Aug 29, 2012Oct 23, 2012Feb 8, 2013Apr 24, 2013Aug 28, 2013Oct 22, 2013Feb 7, 2014Apr 23, 2014Sep 3, 2014Oct 28, 2014Feb 6, 2015Apr 29, 2015Sep 2, 2015Oct 27, 2015Apr 27, 2016Aug 31, 2016Oct 25, 2016Feb 10, 2017Apr 26, 2017Aug 30, 2017Oct 24, 2017Apr 25, 2018Aug 14, 2018Oct 23, 2018Feb 8, 2019Apr 24, 2019Aug 13, 2019Nov 14, 2019Feb 7, 2020May 13, 2020Aug 12, 2020Nov 12, 2020May 14, 2021Aug 13, 2021Nov 18, 2021May 18, 2022Aug 12, 2022Nov 14, 2022Feb 10, 2023May 15, 2023Aug 16, 2023Nov 15, 2023May 14, 2024Aug 13, 2024Nov 13, 2024Mar 19, 2025Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate5770.914934.553981.825138.184898.183789.095116.365211.641466.002952.102207.64883.04176.041236.00832.001032.00--------------------------------------------------------
EPS Actual8130.214046.153617.643955.274545.454570.914840.00164.00964.001788.402988.00-3564.00-376.00772.00-464.00-3356.00-332.43-176.97497.1742.2490.42-152.05-381.52-338.20-414.69-197.07-2951.9176.06-145.95-250.60-937.75-221.00-3370.24-393.65468.7513.9128.15-36.63-14.92-43.93-21.783.73-24.83-0.85-54.5735.95212.0012.11-252.04-20.96-26.9537.0032.8550.2941.5439.491.67-25.04180.04-17.0114.8615.0189.5281.64-110.5264.759.8015.0043.67-32.9143.6559.39
Surprise40.88%-18.00%-9.15%-23.02%-7.20%20.63%-5.40%-96.85%-34.24%-39.42%35.35%-503.61%-313.59%-37.54%-155.77%-425.19%--------------------------------------------------------
TimingAfter-hours-----After-hoursAfter-hours-Pre-marketPre-marketPre-marketPre-marketPre-market-Pre-market--------------------------------------------------------

Key Statistics & Ratios

Market Cap140.97B
Enterprise Value69.23B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.21
Price / Book0.59
Revenue (TTM)116.56B
Gross Profit (TTM)51.79B
EBITDA24.97B
Profit Margin8.60%
Operating Margin17.12%
Return on Equity6.81%
Return on Assets3.49%
Shares Outstanding88.11M
Shares Float56.53M
Beta0.10
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20081×
65.83Dec 29, 2008
20071×
65.83Dec 27, 2007
20061×
1316.68Dec 27, 2006
20051×
1196.98Dec 28, 2005
20041×
1795.47Dec 29, 2004

Stock Splits

  • Apr 26, 20161169:1811
  • Aug 30, 2012593:504
  • Dec 27, 200611:10